Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles

Brain metastases (BM) present a common cause of mortality and morbidity in several metastatic cancer entities. New therapeutic developments during the last decades, including targeted and immune-related therapies, have shown considerable extra- and intracranial response rates in specific subgroups o...

Descripción completa

Detalles Bibliográficos
Autores principales: Steindl, Ariane, Brastianos, Priscilla K, Preusser, Matthias, Berghoff, Anna S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633753/
https://www.ncbi.nlm.nih.gov/pubmed/34859231
http://dx.doi.org/10.1093/noajnl/vdab105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633753/
https://www.ncbi.nlm.nih.gov/pubmed/34859231
http://dx.doi.org/10.1093/noajnl/vdab105

Ejemplares similares